CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 11 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05814419
NCT05814419N/ACompleted

Familial Hyperlipidemia Family Registry

Poudre Valley Health System·observational·Posted Apr 14, 2023·Updated Dec 19, 2025

In Brief

An observational study for Familial Hyperlipidemia. Completed, enrolled 11 participants across 1 site.

Detailed Summary

If a child from the Healthy Hearts and Minds education and screening program is found to have a genetic marker for familial hyperlipidemia (FH), immediate family members are offered genetic testing at no charge to identify those at high risk for cardiovascular disorders and those who carry the genetic markers. If identified early, the risk for cardiovascular disease can be greatly modified by early and proper treatment. The aim of the study is to gauge the impact of large-scale surveillance testing to identify those with the disorder and improve clinical care. This impact is both in disease prevention and in lessening the cost of long-term care from premature cardiovascular disease.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
202420252026
First PostedApr 14, 2023
Enrollment StartFeb 17, 2023
Primary CompletionMay 29, 2025
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 3.2 years ago